Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Dr Adam Lewandowski, who has secured a five-year British Heart Foundation Intermediate Basic Science Fellowship to study the impact of premature birth on the heart.

Adam LewandowskiDr Lewandowski, who works with Prof Paul Leeson in the Cardiovascular Clinical Research Facility will study ‘Cardiac remodelling in preterm-born offspring: defining the importance of early postnatal changes and potential for neonatal dietary interventions to reduce longterm risk’. From previous work we know that the hearts of adults who were born preterm differ in structure and function to adults who were born at term. In previous research, Adam has also found that breast milk feeding in preterm babies is linked to beneficial changes of the heart in adult life. In this current project he will investigate how heart changes in preterm babies progress as they grow up. To do this, he will follow the same preterm volunteers who took part in a study as babies to investigate how their hearts change over time. This will strengthen our understanding of how important the changes that occur in the first months of life are to long-term heart health in people born early. He will also perform further research studying adults born preterm who took part in randomised feeding trials of human breast milk and formula milk when they were babies.

 

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Enterprise Associate Interview with Dr Shilpa Nagarajan

Dr Shilpa Nagarajan is one of the MPLS Enterprise and Innovation Fellows for 2022-23.

The Gene Therapists Headline at Glastonbury 2022

Rosie Munday writes about her experience taking science to the masses at the Glastonbury Festival.

Intensive blood glucose control for people with type 2 diabetes when they are first diagnosed reduces diabetic complications and prolongs life

The study, which tracked volunteers for up to 44 years, showed that the benefits of early intensive blood glucose control can persist for decades.

Wellcome Trust funding success for Jim Hughes and James Davies

£3.6 million in funding awarded by the Wellcome Trust to combine cutting-edge 3D genome technologies with machine learning approaches to decipher the role of the non-coding genome in disease.

Study develops radiotranscriptomic AI analysis to enable virtual heart biopsies

RDM researchers tested the method in COVID-19 patients, to find that the results predicted in-hospital mortality.